Carbidopa, levodopa and entacapone and Haematoma - a phase IV clinical study of FDA data
Haematoma is reported only by a few people who take Carbidopa, Levodopa And Entacapone.
The phase IV clinical study analyzes which people take Carbidopa, levodopa and entacapone and have Haematoma. It is created by eHealthMe based on reports of 294 people who have side effects while taking Carbidopa, levodopa and entacapone from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
294 people reported to have side effects when taking Carbidopa, levodopa and entacapone.
Among them, 4 people (1.36%) have Haematoma.
What is Carbidopa, levodopa and entacapone?
Carbidopa, levodopa and entacapone has active ingredients of carbidopa; entacapone; levodopa. eHealthMe is studying from 298 Carbidopa, levodopa and entacapone users for its effectiveness, alternative drugs and more.
What is Haematoma?
Haematoma (collection of blood outside the blood vessels) is found to be associated with 2,596 drugs and 1,859 conditions by eHealthMe.
Number of Carbidopa, levodopa and entacapone and Haematoma reports submitted per year:
Gender of people who have Haematoma when taking Carbidopa, levodopa and entacapone *:
- female: 100 %
- male: 0.0 %
Age of people who have Haematoma when taking Carbidopa, levodopa and entacapone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Carbidopa, levodopa and entacapone *:
- Apixaban: 4 people, 100.00%
Common side effects people have besides Haematoma *:
- Haemoglobin Decreased: 4 people, 100.00%
- Extravasation (leakage of a fluid): 4 people, 100.00%
Common conditions people have *:
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Carbidopa, levodopa and entacapone and have Haematoma?Check whether Haematoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Haematoma and when was it recovered:
Expand to all the drugs that have ingredients of carbidopa; entacapone; levodopa:
Alternative drugs to, pros and cons of Carbidopa, levodopa and entacapone:
- Carbidopa, levodopa and entacapone (298 reports)
Haematoma treatments and more:
- Haematoma (26,764 reports)
COVID vaccines that are related to Haematoma:
- Haematoma in Moderna COVID Vaccine
- Haematoma in Pfizer BioNTech Covid Vaccine
- Haematoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Haematoma:
All the drugs that are associated with Haematoma:
- Haematoma (2,596 drugs)
Common conditions associated with Haematoma:
All the conditions that are associated with Haematoma:
- Haematoma (1,859 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carbidopa; entacapone; levodopa (the active ingredients of Carbidopa, levodopa and entacapone) and Carbidopa, levodopa and entacapone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Capecitabine and Herpes Zoster - 5 seconds ago
- Etodolac and Benlysta drug interaction - 7 seconds ago
- Silybum and Gastric Ulcer - 9 seconds ago
- Ondansetron and Ventricular Extrasystoles - 10 seconds ago
- Humira and Muscle Abscess - 20 seconds ago
- Dilantin and Migraine With Aura - 22 seconds ago
- Divalproex and Fat Tissue Increased - 22 seconds ago
- Abraxane and Large Intestine Perforation - 25 seconds ago
- Tea Tree Oil and Zofran drug interaction - 25 seconds ago
- Timoptic and Flatulence - 31 seconds ago